{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Pfizer", "item": "https://www.patentleaderboard.com/company/pfizer"}, {"@type": "ListItem", "position": 3, "name": "Harry Howard", "item": "https://www.patentleaderboard.com/inventor/fl:ha_ln:howard-3"}]}

Home › Pfizer › Harry Howard

HH

Harry Howard — 64 Patents

Pfizer: 47 patents #20 of 5,153Top 1%

MEMedisynergics: 10 patents #1 of 3Top 35%

TATeknor Apex: 3 patents #19 of 79Top 25%

WCWarner-Lambert Company: 1 patents #930 of 1,610Top 60%

Bristol, CT: #1 of 363 inventorsTop 1%

Connecticut: #294 of 34,797 inventorsTop 1%

Overall (All Time): #34,494 of 4,157,543Top 1%

64 Patents All Time

Harry Howard has been granted 64 US patents while listed as an inventor at Pfizer. The first was granted in 1984 and the most recent in August 2022. Harry Howard ranks #34,494 of 4,157,543 US inventors in our database (top 0.83%). Patent records list Harry Howard in Bristol, CT, US.

Patents per Year

Issued Patents All Time

Showing 1–25 of 64 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11426411	Cycloalkyl-diamines for the treatment of inflammation	Dennis Michael Godek, Andrew Morgan Stewart	2022-08-30
11007200	Cycloalkyl-diamines for the treatment of pain	Dennis Michael Godek, Andrew Morgan Stewart	2021-05-18
10351552	Bicyclic antiparasitic compounds	Dennis Michael Godek, Shawn-Michael Rodriguez	2019-07-16
9700563	Kappa opioid receptor compounds	Dennis Michael Godek	2017-07-11
9517232	Compounds for treatment of alzheimer's disease	Dennis Michael Godek	2016-12-13
9475788	Antiprotozoal compounds	Dennis Michael Godek	2016-10-25
9381170	Cycloalkyl-diamines for neurodegenerative disorders	Dennis Michael Godek	2016-07-05
9345673	Anti-cancer cycloalkyl diamines	Dennis Michael Godek	2016-05-24
9346777	Antiprotozoal compounds	Dennis Michael Godek	2016-05-24
9283196	Cycloalkyl-diamines for CNS disorders	Dennis Michael Godek	2016-03-15
9284291	Kappa opioid receptor compounds	Dennis Michael Godek	2016-03-15
9169237	Antiprotozoal amidine compounds	Dennis Michael Godek	2015-10-27
9126891	Cycloalkyl-diamines	Dennis Michael Godek	2015-09-08
7557162	Toughened polymer compositions	Raman Patel, Marc Caruthers, Tonya McBride, John J. Wood, III, John Andries	2009-07-07
7129234	Phenyl heterocyclyl ethers	Mavis Adam, Mark Andrews, Geoffrey E. Gymer, David Hepworth, Donald Middleton +1 more	2006-10-31	$291,859,000
7101886	Phenylalkyl and pyridylalkyl piperazine derivatives	Stephen Sung Yong Cho, Jamie Singer, James Graham, Tracy Gregory, Sham Nikam +1 more	2006-09-05
7084165	Monoamine reuptake inhibitors for treatment of CNS disorders	Christopher Schmidt, Thomas Seeger, Mark Elliot	2006-08-01	$226,128,000
7041741	Toughened polymer compositions	Raman Patel, Marc Caruthers, Tonya McBride, John J. Wood, III, John Andries	2006-05-09
6924289	Benzyl(Idene)-lactam derivatives, their preparation and their use as selective (ANT) agonists of 5-HT1A- and/or 5-HT1D receptors	—	2005-08-02	$211,477,000
6921760	Aralkyl and aralkylidene heterocyclic lactams and imides	—	2005-07-26	$350,490,000
6677378	Monoamine reuptake inhibitors for treatment of CNS disorders	Christopher Schmidt, Thomas Seeger, Mark Elliott	2004-01-13	$358,177,000
6627627	Aralkyl and aralkylidene heterocyclic lactams and imides	—	2003-09-30	$173,502,000
6610747	Phenoxybenzylamine derivatives as SSRIs	Mavis Adam, Mark Andrews, Mark Elliott, Geoffrey E. Gymer, David Hepworth +2 more	2003-08-26	$177,412,000
6602874	Heterocyclic carboxamides	—	2003-08-05	$285,366,000
6596741	Biaryl ether derivatives useful as monoamine reuptake inhibitors	Mavis Adam	2003-07-22	$350,518,000